Rapid Micro Biosystems (RPID) EBT (2020 - 2026)

Rapid Micro Biosystems has disclosed EBT across 7 years of filings, most recently posting -$12.9 million for Q2 2026.

• In Q2 2026, EBT fell 8.7% year-over-year to -$12.9 million; the TTM figure through Jun 2026 stood at -$51.1 million (down 15.96% YoY), while the FY2025 annual figure was -$47.1 million, changed 0.46% from the prior year.
• EBT came in at -$12.9 million for Q2 2026 at Rapid Micro Biosystems, up from -$14.3 million in the prior quarter.
• In the past five years, EBT ranged from a high of -$9.7 million in Q4 2024 to a low of -$16.4 million in Q4 2022.
• Average EBT over 5 years is -$13.1 million, with a median of -$13.1 million recorded in 2024.
• Year-over-year, EBT surged 34.59% in 2022 and declined 29.02% in 2025.
• Over 5 years, EBT stood at -$16.4 million in 2022, then soared by 32.09% to -$11.2 million in 2023, then grew by 13.34% to -$9.7 million in 2024, then decreased by 29.02% to -$12.5 million in 2025, then decreased by 3.16% to -$12.9 million in 2026.
• Per Business Quant data, the three most recent EBT figures were -$12.9 million in Q2 2026, -$14.3 million in Q1 2026, and -$12.5 million in Q4 2025.